Canada approves 1st generic semaglutide shot for weight loss - BERITAJA

Health Canada has approved the first generic semaglutide injection for weight loss.

The merchandise from the Canadian institution Apotex is known arsenic Svemia and is simply a generic type of the brand-name supplier Wegovy from Denmark’s Novo Nordisk.

Health Canada says Svemia is for the once-weekly curen of group 12 and over, arsenic a supplement to a reduced-calorie fare and accrued beingness activity for chronic weight management.

It’s the 3rd generic semaglutide merchandise approved by the department, though the first 2 were authorized for the curen of Type 2 glucosuria successful adults.

Generic versions of Novo Nordisk’s Ozempic by India-based Dr. Reddy’s Laboratories and Apotex were approved earlier this year.

Health Canada says it’s reviewing six different submissions for generic semaglutide from different companies and expects to make much decisions successful the coming weeks and months.